Swiss green light for stem cell research
This article was originally published in Clinica
Executive Summary
The Swiss upper house of parliament, the Bundesrat, has passed a law allowing the use of stem cells harvested from surplus embryos (that have been produced in vitro for via artificial insemination) to be used for research purposes. The law will enter into force on March 1. Some 66% of voters in a public referendum on the subject last November (see Clinica 1136, p 2) said they would be favourable to such a law, which they considered would bring nearer the possibility of cures for diabetes, Alzheimer's and other diseases.